Long-Term Study Suggests Extended Relief from Atopic Dermatitis After Topical Treatment
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
Data show most patients maintained mild disease for over two months without treatment following initial clearance in a 48-week extension trial.
The Women and Equalities Committee's report highlights patient safety failures tied to unregulated surgical and non-surgical cosmetic procedures, including gaps in data collection, informed consent, and clinical oversight.